Genome sequence of a serotype M3 strain of group A Streptococcus: Phage-encoded toxins, the high-virulence phenotype, and clone emergence

Genome sequences are available for many bacterial strains, but there has been little progress in using these data to understand the molecular basis of pathogen emergence and differences in strain virulence. Serotype M3 strains of group A Streptococcus (GAS) are a common cause of severe invasive infections with unusually high rates of morbidity and mortality. To gain insight into the molecular basis of this high-virulence phenotype, we sequenced the genome of strain MGAS315, an organism isolated from a patient with streptococcal toxic shock syndrome. The genome is composed of 1,900,521 bp, and it shares ≈1.7 Mb of related genetic material with genomes of serotype M1 and M18 strains. Phage-like elements account for the great majority of variation in gene content relative to the sequenced M1 and M18 strains. Recombination produces chimeric phages and strains with previously uncharacterized arrays of virulence factor genes. Strain MGAS315 has phage genes that encode proteins likely to contribute to pathogenesis, such as streptococcal pyrogenic exotoxin A (SpeA) and SpeK, streptococcal superantigen (SSA), and a previously uncharacterized phospholipase A2 (designated Sla). Infected humans had anti-SpeK, -SSA, and -Sla antibodies, indicating that these GAS proteins are made in vivo. SpeK and SSA were pyrogenic and toxic for rabbits. Serotype M3 strains with the phage-encoded speK and sla genes increased dramatically in frequency late in the 20th century, commensurate with the rise in invasive disease caused by M3 organisms. Taken together, the results show that phage-mediated recombination has played a critical role in the emergence of a new, unusually virulent clone of serotype M3 GAS.

[1]  J. Musser,et al.  Molecular Analysis of Group A Streptococcus Type emm18 Isolates Temporally Associated with Acute Rheumatic Fever Outbreaks in Salt Lake City, Utah , 2002, Journal of Clinical Microbiology.

[2]  Todd M. Smith,et al.  Genome sequence and comparative microarray analysis of serotype M18 group A Streptococcus strains associated with acute rheumatic fever outbreaks , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[3]  B. Schwartz,et al.  Severe group a streptococcal soft-tissue infections in Ontario: 1992-1996. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[4]  J. Mekalanos,et al.  A genome-scale analysis for identification of genes required for growth or survival of Haemophilus influenzae , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[5]  J. Musser,et al.  Evasion of human innate and acquired immunity by a bacterial homolog of CD11b that inhibits opsonophagocytosis , 2001, Nature Medicine.

[6]  J. Musser,et al.  Evolutionary genomics of pathogenic bacteria. , 2001, Trends in microbiology.

[7]  M. Dinges,et al.  Comparative Analysis of Lipopolysaccharide-Induced Tumor Necrosis Factor Alpha Activity in Serum and Lethality in Mice and Rabbits Pretreated with the Staphylococcal Superantigen Toxic Shock Syndrome Toxin 1 , 2001, Infection and Immunity.

[8]  Magnus Rasmussen,et al.  Improved Pattern for Genome-Based Screening Identifies Novel Cell Wall-Attached Proteins in Gram-Positive Bacteria , 2001, Infection and Immunity.

[9]  Bruce A. Roe,et al.  Complete genome sequence of an M1 strain of Streptococcus pyogenes , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[10]  Bacterial polymorphisms and disease in humans. , 2001, The Journal of clinical investigation.

[11]  J. Musser,et al.  Group A Streptococcus: allelic variation, population genetics, and host-pathogen interactions. , 2001, The Journal of clinical investigation.

[12]  J. Musser,et al.  Identification and Characterization of thescl Gene Encoding a Group A StreptococcusExtracellular Protein Virulence Factor with Similarity to Human Collagen , 2000, Infection and Immunity.

[13]  J. Musser,et al.  Identification and Immunogenicity of Group AStreptococcus Culture Supernatant Proteins , 2000, Infection and Immunity.

[14]  D. Ohlendorf,et al.  Development of Streptococcal Pyrogenic Exotoxin C Vaccine Toxoids That Are Protective in the Rabbit Model of Toxic Shock Syndrome1 , 2000, The Journal of Immunology.

[15]  M. Cunningham,et al.  Pathogenesis of group A streptococcal infections. , 2000, Clinical microbiology reviews.

[16]  I. Longden,et al.  EMBOSS: the European Molecular Biology Open Software Suite. , 2000, Trends in genetics : TIG.

[17]  Yun-Xin Fu,et al.  Rapid selection of complement-inhibiting protein variants in group A Streptococcus epidemic waves , 1999, Nature Network Boston.

[18]  J. Musser,et al.  Rapid molecular genetic subtyping of serotype M1 group A Streptococcus strains. , 1999, Emerging infectious diseases.

[19]  L. Björck,et al.  Identification of an Insertion Sequence Located in a Region Encoding Virulence Factors of Streptococcus pyogenes , 1998, Infection and Immunity.

[20]  M. Sellin,et al.  Identification of a novel insertion element, IS1548, in group B streptococci, predominantly in strains causing endocarditis. , 1998, The Journal of infectious diseases.

[21]  J. Musser,et al.  Inactivation of Streptococcus pyogenes extracellular cysteine protease significantly decreases mouse lethality of serotype M3 and M49 strains. , 1997, The Journal of clinical investigation.

[22]  B. Schwartz,et al.  Survey of emm gene sequences and T-antigen types from systemic Streptococcus pyogenes infection isolates collected in San Francisco, California; Atlanta, Georgia; and Connecticut in 1994 and 1995 , 1997, Journal of clinical microbiology.

[23]  J. Vuopio‐Varkila,et al.  Molecular comparison of group A streptococci of T1M1 serotype from invasive and noninvasive infections in Finland. , 1997, The Journal of infectious diseases.

[24]  S. Brunak,et al.  SHORT COMMUNICATION Identification of prokaryotic and eukaryotic signal peptides and prediction of their cleavage sites , 1997 .

[25]  R. Cook,et al.  Species-dependent post-translational modification and position 2 allelism: effects on streptococcal superantigen SSA structure and V beta specificity. , 1996, Journal of immunology.

[26]  A. Bisno,et al.  Identification of a fibronectin-binding protein (GfbA) in pathogenic group G streptococci , 1996, Infection and immunity.

[27]  J. Musser,et al.  Phylogenetic distribution of streptococcal superantigen SSA allelic variants provides evidence for horizontal transfer of ssa within Streptococcus pyogenes , 1996, Infection and immunity.

[28]  J. Musser Molecular population genetic analysis of emerged bacterial pathogens: selected insights. , 1996, Emerging infectious diseases.

[29]  J. Ferretti,et al.  Analysis of a second bacteriophage hyaluronidase gene from Streptococcus pyogenes: evidence for a third hyaluronidase involved in extracellular enzymatic activity , 1995, Infection and immunity.

[30]  I. Sutcliffe,et al.  Lipoproteins of gram-positive bacteria , 1995, Journal of bacteriology.

[31]  J. Musser,et al.  Genetic diversity and relationships among Streptococcus pyogenes strains expressing serotype M1 protein: recent intercontinental spread of a subclone causing episodes of invasive disease , 1995, Infection and immunity.

[32]  J. Musser,et al.  Characterization and distribution of insertion sequence IS1239 in Streptococcus pyogenes. , 1994, Gene.

[33]  J. Musser,et al.  Vaccination with streptococcal extracellular cysteine protease (interleukin-1 beta convertase) protects mice against challenge with heterologous group A streptococci. , 1994, Microbial pathogenesis.

[34]  M. Gasson,et al.  Characterization of IS905, a new multicopy insertion sequence identified in lactococci , 1994, Journal of bacteriology.

[35]  J. Musser,et al.  Molecular characterization and phylogenetic distribution of the streptococcal superantigen gene (ssa) from Streptococcus pyogenes , 1994, Infection and immunity.

[36]  J. Musser,et al.  Temporal variation in bacterial disease frequency: molecular population genetic analysis of scarlet fever epidemics in Ottawa and in eastern Germany. , 1993, The Journal of infectious diseases.

[37]  M. Howden,et al.  Studies on the subunit structure of textilotoxin, a potent presynaptic neurotoxin from the venom of the Australian common brown snake (Pseudonaja textilis). 3. The complete amino-acid sequences of all the subunits. , 1993, Biochimica et biophysica acta.

[38]  D. Musher,et al.  Geographic and temporal distribution and molecular characterization of two highly pathogenic clones of Streptococcus pyogenes expressing allelic variants of pyrogenic exotoxin A (Scarlet fever toxin). , 1993, The Journal of infectious diseases.

[39]  E. Dennis,et al.  Analysis of human synovial fluid phospholipase A2 on short chain phosphatidylcholine-mixed micelles: development of a spectrophotometric assay suitable for a microtiterplate reader. , 1992, Analytical biochemistry.

[40]  J. Musser,et al.  Streptococcus pyogenes causing toxic-shock-like syndrome and other invasive diseases: clonal diversity and pyrogenic exotoxin expression. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[41]  P. Schlievert,et al.  Fluid replacement protection of rabbits challenged subcutaneous with toxic shock syndrome toxins , 1991, Infection and immunity.

[42]  C. Rubens,et al.  IS861, a group B streptococcal insertion sequence related to IS150 and IS3 of Escherichia coli , 1989, Journal of bacteriology.

[43]  D. Botstein A THEORY OF MODULAR EVOLUTION FOR BACTERIOPHAGES * , 1980, Annals of the New York Academy of Sciences.

[44]  P. Schlievert,et al.  Group A streptococcal pyrogenic exotoxin: pyrogenicity, alteration of blood-brain barrier, and separation of sites for pyrogenicity and enhancement of lethal endotoxin shock , 1978, Infection and immunity.